The ICOAP is an 11-item measure that assesses pain in individuals with hip or knee osteoarthritis taking into account both constant and intermittent pain experiences.
11
10 minutes
Adult
18 - 64
yearsElderly Adult
65 +
yearsInitially reviewed by Vaidehi Datar, PT, MHS.
Do you see an error or have a suggestion for this instrument summary? Please e-mail us!
Patients with Hip or Knee OA: (Singh, 2014; n = 195; 141 knee OA patients and 54 hip OA patients)
Patients with Hip or Knee OA (Singh, 2014)
MCID for total pain:
MCID for constant pain:
MCID for intermittent pain:
Patients with Hip or Knee OA (Singh, 2014)
Patients with Hip or Knee OA (Hawker et al, 2008)
Patients with Hip and Knee OA (Bombardier et al, 1995; n = 76, age ≥ 40 years)
Patients with Hip and Knee OA (Manolarakis et al, 2016; n = 89, mean age = 71.07; with 2 treatment cycles of 4 intra-articular injections of sodium hyaluronate for the OA pain)
Patients with Hip and Knee OA (Hawker et al, 2008)
Patients with Hip and Knee OA (Manolarakis et al, 2016)
Patients with Hip and Knee OA (Hawker et al, 2008) descriptive analyses of items demonstrated good distribution of response options across all items.
Patients with Hip and Knee OA (Hawker et al, 2008)
Patients with Hip and Knee OA (Manolarakis et al, 2016)
Patients with Hip and Knee OA (Hawker et al, 2008)
Patients with Knee OA (Gonçalves et al, 2012; n = 109; age> 50unilateral or bilateral severe Knee OA validated according to clinical and radiological criteria of American College of Rheumatology)
Floor effects were considered to be present when more than 15% of the patients received the lowest possible score on pre-treatment ICOAP subscales and total pain.
Patients with Knee OA (Gonçalves et al, 2012)
Ceiling effects were considered to be present when more than 15% of the patients received the highest possible score on pre-treatment ICOAP subscales and total pain score
Patients with Knee OA (Gonçalves et al, 2012)
Bombardier, C., Melfi, C., Paul, J., Green, R., Hawker, G., Wright, J., & Coyote, P. (1995). Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgery. Med Care, 33(4), 131-144.
Gonçalves, R., Meireles, A., Gil, J., Cavalheiro, L., Rosado, J., & Cabri, J. (2012). Responsiveness of intermittent and constant osteoarthritis pain (ICOAP) after physical therapy for knee osteoarthritis. Osteoarthritis and Cartilage, 20(10), 1116-1119.
Hawker, G., Davis, A., French, M., Cibere, J., Jordan, J., March, L., . . . Dieppe, P. (2008). Development and preliminary psychometric testing of a new OA pain measure – an OARSI/OMERACT initiative. Osteoarthritis and Cartilage, 16(4), 409-414.
Hawker GA, Mian S, Kendzerska T, French M. (2011). Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36). Arthritis Care Res Arthritis Care & Research, 63(S11).
Manolarakis GE, Kontodimopoulos N, Sifaki-Pistolla D, Niakas D. (2016). Establishing the Psychometric Properties of the ICOAP Questionnaire through Intra-Articular Treatment of Osteoarthritic Pain: Implementation for the Greek Version. Arthritis 2016;1–11.
Maillefert, J., Kloppenburg, M., Fernandes, L., Punzi, L., Günther, K., Mola, E. M., . . . Hawker, G. (2009). Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP). Osteoarthritis and Cartilage, 17(10), 1293-1296.
Moreton, B., Wheeler, M., Walsh, D., & Lincoln, N. (2012). Rasch analysis of the intermittent and constant osteoarthritis pain (ICOAP) scale. Osteoarthritis and Cartilage, 20(10), 1109-1115.
Singh, J. A., Luo, R., Landon, G. C., & Suarez-Almazor, M. (2014). Reliability and Clinically Important Improvement Thresholds for Osteoarthritis Pain and Function Scales: A Multicenter Study. The Journal of Rheumatology, 41(3), 509-515.
We have reviewed more than 500 instruments for use with a number of diagnoses including stroke, spinal cord injury and traumatic brain injury among several others.